ENKAM Pharmaceuticals A/S

____________________________________

ENKAM Pharmaceuticals A/S is a Copenhagen-based biotechnology company focused on the discovery and development of peptides for the treatment of CNS disorders and cancer; and for stem cell applications. Enkam has used structural proteomics tools and bio-informatics on protein-protein interactions to discover bioactive peptides. Over 50 peptide families have been identified and patents covering them have been filed. In Q4 2011 the EU awarded a €6 million grant to an Enkam-led consortium following extensive peer review to fund a clinical study in Alzheimer's disease of Enkam's novel lead development candidate, FGLs, which has demonstrated positive effects in neurodegeneration in Alzheimer's disease.